SHL Medical Revenue and Competitors

Miami, FL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • SHL Medical's estimated annual revenue is currently $111.4M per year.(i)
  • SHL Medical's estimated revenue per employee is $251,000

Employee Data

  • SHL Medical has 444 Employees.(i)

SHL Medical's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.1M1040%$63.5MN/A
#2
$14.3M57-8%N/AN/A
#3
$33.1M1326%N/AN/A
#4
$10.8M435%N/AN/A
#5
$488.3M12160%N/AN/A
#6
$14.3M5710%N/AN/A
#7
$5M20-9%N/AN/A
#8
$95.6M381-1%N/AN/A
#9
$16.8M673%N/AN/A
#10
$57M22713%N/AN/A
Add Company

What Is SHL Medical?

SHL Group is a world-leading designer, developer and manufacturer of advanced drug delivery devices. We have over 3,700 staff globally, with our primary design centers in the U.S. and Sweden and manufacturing centers located in Asia. SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities. We comprise three distinct group companies: SHL Medical Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies. Also provides final assembly, labeling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries SHL Healthcare Develops and manufactures equipment solutions for home, hospital and long-term care use SHL Technologies Provides contract manufacturing and engineering services for the production of complex medtech and industrial products

keywords:N/A

N/A

Total Funding

444

Number of Employees

$111.4M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

SHL Medical News

2022-04-13 - Injectable Devices for Subcutaneous Self-administration Market Research Report 2022: Assess the Importance of Alliances and Partnerships on Subcutaneous Drug Product Commercialization

Molly (SHL Medical). Molly RNS (SHLMedical). Bertha (SHL Medical). Maggie (SHL Medical). Amber (SHL Medical). SafeLock (SHL Medical).

2022-04-13 - Injectable Devices for Subcutaneous Self-administration Market Research Report 2022: Assess the Importance of Alliances and Partnerships on Subcutaneous Drug Product Commercialization

Molly (SHL Medical). Molly RNS (SHLMedical). Bertha (SHL Medical). Maggie (SHL Medical). Amber (SHL Medical). SafeLock (SHL Medical).

2022-03-30 - Injectable Drug Delivery Market Size to Reach USD 83.38 ...

Increasing application in medical surgeries is a major factor driving ... Gerresheimer AG, Elcam Medical, Schott, SHL Medical AG, Becton,...

2022-03-30 - Injectable Drug Delivery Market Size to Reach USD 83.38 ...

Increasing application in medical surgeries is a major factor driving ... Gerresheimer AG, Elcam Medical, Schott, SHL Medical AG, Becton,...

2020-03-30 - SHL Medical Buys Weibel CDS

SHL Medical, a Zug, Switzerland-based technology frontrunner in the self-injection industry, acquired Weibel CDS, a medical technology company offering products and solutions for drug delivery and novel packaging. The amount of the deal was not disclosed. With the acquisition, SHL is expected ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$136.4M496-11%N/A
#2
$75M6024%N/A
#3
$267.7M6499%N/A
#4
$35M6625%N/A
#5
$283M6866%N/A